Male Physicians Receive More and Higher Payments From Medical Companies
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Male physicians receive significantly higher...
Otolaryngology
Guideline Developed for Assessing Penicillin Allergies
MONDAY, Oct. 3, 2022 (HealthDay News) — In a clinical practice guideline issued by the...
Warning Labels on High-Powered Magnets Unlikely to Prevent Child Injuries
MONDAY, Oct. 3, 2022 (HealthDay News) — Parents of children with high-powered magnet...
Research & Development Investments Do Not Explain Drug Price Variation
MONDAY, Oct. 3, 2022 (HealthDay News) — For a sample of 60 drugs, research and development...
Medicare Eligibility Linked to Improvements in Health Care Access
TUESDAY, Oct. 4, 2022 (HealthDay News) — Medicare eligibility and enrollment at age 65 years...
Medicare Monthly Premiums to Drop for Seniors
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Millions of seniors who had to pay high...
#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma
Click to read this study in Clinical Cancer Research.Â
American Academy of Otolaryngology-Head and Neck Surgery, Sep. 10-14
The annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery was held in...
Physician Burnout Significantly Increased During 2020 to 2021
FRIDAY, Sept. 23, 2022 (HealthDay News) — A dramatic increase in burnout occurred in U.S....
Active Surveillance Feasible for Low-Risk Thyroid Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Active surveillance may be a viable strategy for...
MRI Techniques Compared for Assessing Hydrops in Meniere Disease
TUESDAY, Sept. 20, 2022 (HealthDay News) — For patients with Meniere disease (MD),...
Smoking May Increase Odds of Meniere Disease in Men
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — For men, smoking is positively related and...
